P-089: evaluation of safety and efficacy of hbs-sailin®: a potent ingenious anti-sickling agent that reduces pain and improves the quality of life in sickle cell patients.
HemaSphere（2022）
关键词
sickle cell patients,hbs-sailin,anti-sickling
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要